Roche Protected: Immunotherapy combination now PBS listed for first-line treatment of metastatic non-squamous non-small cell lung cancer (1,2) By ONA Editor October 1, 2019 No Comments Share Tweet Pinterest LinkedIn Tumblr Email + Prime Minister of Australia, The Hon. Scott Morrison MP with General Manager of Roche Australia, Stuart Knight This content is password-protected. To view it, please enter the password below. Password: Share. Twitter Facebook Pinterest LinkedIn Tumblr Email
AACR 2026: Long-term use of immunotherapy may be safe for patients with alveolar soft part sarcoma May 2, 2026 0
Does biological age matter more than chronological age in NSCLC? New AI-derived facial age data suggest added prognostic value April 21, 2026 0
Chrono-oncology: Earlier-day immunochemotherapy delivery may be associated with improved outcomes in advanced NSCLC February 14, 2026 0